SAFETY AND EFFICACY OF LUMACAFTOR/IVACAFTOR IN PEDIATRIC CYSTIC FIBROSIS PATIENTS

被引：0
|
作者：
Wainwright, C. [1 ]
Chilvers, M. [2 ]
Hug, C. [3 ]
Marigowda, G. [3 ]
Tian, S. [3 ]
Solomon, M. [4 ]
Black, P. [5 ]
Rosenfeld, M. [6 ]
Sawicki, G. [7 ]
Hoppe, J. [8 ]
机构：
[1] Lady Cilento Childrens Hosp, South Brisbane, Australia
[2] British Columbia Childrens Hosp, Vancouver, BC, Canada
[3] Vertex Pharmaceut Inc, Boston, MA USA
[4] Hosp Sick Children, Toronto, ON, Canada
[5] Childrens Mercy Hosp, Kansas City, MO 64108 USA
[6] Univ Washington, Sch Med, Seattle Childrens Hosp, Seattle, WA 98195 USA
[7] Harvard Med Sch, Boston, MA USA
[8] Univ Colorado, Sch Med, Childrens Hosp Colorado, Boulder, CO 80309 USA
来源：
RESPIROLOGY | 2018年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
TP 068
引用
收藏
页码：141 / 141
页数：1
相关论文
共 50 条
  • [31] Factors Predisposing the Response to Lumacaftor/Ivacaftor in People with Cystic Fibrosis
    Mesinele, Julie
    Ruffin, Manon
    Guillot, Loic
    Boelle, Pierre-Yves
    Corvol, Harriet
    French CF Modifier Gene Study Investigators
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (02):
  • [32] Reduced Intestinal Inflammation With Lumacaftor/Ivacaftor in Adolescents With Cystic Fibrosis
    Tetard, Candice
    Mittaine, Marie
    Bui, Stephanie
    Beaufils, Fabien
    Maumus, Pascale
    Fayon, Michael
    Burgel, Pierre-Regis
    Lamireau, Thierry
    Delhaes, Laurence
    Mas, Emmanuel
    Enaud, Raphael
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2020, 71 (06): : 778 - 781
  • [33] How Clinically Efficient Are Lumacaftor/Ivacaftor for Cystic Fibrosis Patients: An Updated Literature Review
    Perveen, Sumera
    Chaudhry, Muhammad Reza
    AlBabtain, Sarah
    Amreen, Sana
    Brar, Simrandeep K.
    Zeb, Mehwish
    Khan, Safeera
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (12)
  • [34] SAFETY AND REAL WORLD NUTRITIONAL EFFECTIVENESS OF LUMACAFTOR-IVACAFTOR IN CHILDREN WITH CYSTIC FIBROSIS AT FOUR NEMOURS CYSTIC FIBROSIS CENTERS
    Greenawald, L.
    Shenoy, A.
    Peeke, K.
    Elidemir, O.
    Livingston, F.
    Schaeffer, D.
    Chidekel, A.
    PEDIATRIC PULMONOLOGY, 2017, 52 : S318 - S318
  • [35] Lumacaftor/ Ivacaftor improves exercise tolerance in patients with Cystic Fibrosis and severe airflow obstruction
    Wark, Peter A. B.
    Cookson, Kim
    Thiruchelvam, Theeba
    Brannan, John
    Dorahy, Douglas J.
    BMC PULMONARY MEDICINE, 2019, 19 (1)
  • [36] Computed Tomographic Changes in Patients with Cystic Fibrosis Treated by Combination Therapy with Lumacaftor and Ivacaftor
    Arnaud, Francois
    Stremler-Le Bel, Nathalie
    Reynaud-Gaubert, Martine
    Mancini, Julien
    Gaubert, Jean-Yves
    Gorincour, Guillaume
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (09)
  • [37] Patients with cystic fibrosis and advanced lung disease benefit from lumacaftor/ivacaftor treatment
    Ejiofor, Linnea Chika Kristensen
    Mathiesen, Inger Hee Mabuza
    Jensen-Fangel, Soren
    Olesen, Hanne Vebert
    Skov, Marianne
    Philipsen, Lue Katrine Drasbaek
    Pedersen, Camilla Lundgren
    Pressler, Tacjana
    PEDIATRIC PULMONOLOGY, 2020, 55 (12) : 3364 - 3370
  • [38] Lumacaftor/ Ivacaftor improves exercise tolerance in patients with Cystic Fibrosis and severe airflow obstruction
    Peter A. B. Wark
    Kim Cookson
    Theeba Thiruchelvam
    John Brannan
    Douglas J. Dorahy
    BMC Pulmonary Medicine, 19
  • [39] COST EFFECTIVENESS OF IVACAFTOR AND LUMACAFTOR COMBINATION FOR THE TREATMENT OF PATIENTS WITH CYSTIC FIBROSIS IN THE UNITED STATES
    Sharma, D.
    Xing, S.
    Hung, Y.
    Caskey, R. N.
    Dowell, M. L.
    Touchette, D. R.
    VALUE IN HEALTH, 2016, 19 (07) : A431 - A432
  • [40] Real World Assessment of Patients with Cystic Fibrosis Treated with Lumacaftor-Ivacaftor and Transitioned to Tezacaftor-Ivacaftor
    Christmas, A.
    O'Hagan, A. R.
    Morton, R. L.
    Eid, N. S.
    Bickel, S. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
12345